李飞泽，1989年12月生，博士，副研究员，博士生导师。2013年毕业于四川大学化学学院放射化学专业，获学士学位；2016年毕业于四川大学核能与核技术工程专业，获硕士学位；2019年毕业于四川大学核燃料循环与材料专业，获博士学位；2016-2019年在中国科学院高能物理研究所从事锕系配位化学研究；2019年9月进入四川大学原子核科学技术研究所工作。现任中国核学会核化学与放射化学分会理事、中国核学会放射性药物分会理事、中国同位素与辐射行业协会放射性药物分会理事、中国核学会核测试与分析分会理事、中国核工业学会教育学会核医学人才分会委员；四川省核学会同位素分会理事、四川省抗癌协会肿瘤核医学专委会委员；日本福岛县立医科大学特别研究员。

       目前主要从事核化学与放射化学、新型超分子放射性药物、加速器核素的制备及应用等领域的研究工作。已在Nat. Commun.、Eur. J. Med. Chem.、Carbon、Chem. Mater.、ACS Appl Mater Inter.、Inorg. Chem.、Chem. Eur. J、Mol. Pharmaceut.等知名学术期刊上发表学术论文90余篇，其中作为第一或通讯作者40余篇；获批国家发明专利9项；先后主持承担国家自然科学基金、中日笹川医学合作项目、中国博士后基金、四川省科技厅研究项目等多个科研课题。

电子邮箱：lifeize@scu.edu.cn

主要研究领域：

1. 新型超分子放射性药物

​2. 加速器核素的制备及应用

Associate professor, Ph.D.

Institute of Nuclear Science and Technology

Sichuan University

Chengdu 610064, China

Tel: +86-28-85412613

E-mail: lifeize@scu.edu.cn

Education and Experience

2019.09-2021.08: Institute of Nuclear Science and Technology, Sichuan University, Associate Professor.

2019.09-2021.08: Institute of Nuclear Science and Technology, Sichuan University, Assistant Professor.

2016.09-2019.06: Institute of High Energy Physics, Chinese Academy of Sciences, Visiting Ph.D.

2013.09-2016.06: Institute of Nuclear Science and Technology, Sichuan University, M.S.

2009.09-2013.06: College of Chemistry, Sichuan University, B.S.

Interests:

1. Supramolecular Chemistry and Radiopharmaceutical

2. Application of Accelerator-Produced Radioisotopes

代表性论文和成果

文章列表：

1. Xisheng Fan, Guoquan Ma, Haiyue Peng, Jing Gao, Yingjiang Hu, Bo Li, Jiali Liao, Yuanyou Yang, Jinsong Zhang, Lijian Ma, Ning Liu*, Feize Li*, Yolk-Shell Pst@SiO₂ decorated with functional guests: A new solid-phase extractant for highly effective separation of no carrier added ¹⁷⁷Lu. Separation and Purification Technology, 2025, 356, 129802

2. Tianzhen Ye, Yuying Yu, Guofeng Qu, Huan Ma, Shilong Shi, Jiujian Ji, Jie Lyu, Yuanyou Yang, Ning Liu*, Feize Li*. European Journal of Medicinal Chemistry, 2024, 279: 116919.

3. Feize Li, Huan Ma, Hao Luo, Guohua Shen*, Jing Su, Huawei Cai, Xijian Chen, Tu Lan, Yuanyou Yang, Jiali Liao, Ning Liu*. ²¹¹At-labeled polydopamine decorated with FAPI for synergistic targeted-alpha therapy and photothermal therapy of gliom. ACS Applied Nano Materials, 2024, 7: 6831.

4. Long Qiu, Jianrong Wu, Ning Luo, Qian Xiao, Junshan Geng, Lingting Xia, Jiali Liao, Yuanyou Yang, Ning Liu, Jinsong Zhang* and Feize Li*. Preparation of Medical ²²⁸Th-²²⁴Ra Radionuclide Generator Based on SiO₂@TiO₂ Microspheres, Langmuir 2024, 40, 11723-11731.

5. Haiyue Peng, Feize Li*, Yilin Qin, Shilong Shi, Guoquan Ma, Xisheng Fan, Yang Li, Lijian Ma, Ning Liu*. Branched-chain-induced host-guest assembly in covalent-organic frameworks for efficient separation of no-carrier-added ¹⁷⁷Lu. ACS Applied Materials & Interfaces, 2024, 16: 9343.

6. Guoquan Ma, Haiyue Peng, Xisheng Fan, Yang Li, Jing Gao, Yingjiang Hu, Bo Li, Yuanyou Yang, Jingsong Zhang, Lijian Ma, Ning Liu, Jiali Liao*, Feize Li*. Shape-persistent COF-derived functional carbon microspheres for No-carrier added ¹⁷⁷Lu separation. Carbon 2024, 225, 119035

7. Tianzhen Ye, Yilin Qin, Weihao Liu, Lingting Xia, Jiali Liao, Jijun Yang, Tu Lan, Yuanyou Yang, Ning Liu*, Feize Li*, A new strategy for facile and rapid separation of astatine-211 from nitric acid medium. Separation and Purification Technology. 2024, 330, 125284

8. Xijian Chen, Fuyuan Tan, Ranxi Liang, Jiali Liao, Jijun Yang, Tu Lan,Yuanyou Yang, Ning Liu*, Feize Li*. A proof-of-concept study on the theranostic potential of ¹⁷⁷Lu-labeled biocompatible covalent polymer nanoparticles for cancer targeted radionuclide therapy. Chemistry-A European Journal, 2024, 30, e202303298.

9. Ranxi Liang, Feize Li*, Xijian Chen, Fuyuan Tan, Tu Lan, Jijun Yang, Jiali Liao, Yuanyou Yang, Ning Liu*. Multimodal Imaging-Guided Strategy for Developing ¹⁷⁷Lu-Labeled Metal-Organic Framework Nanomedicine with Potential in Cancer Therapy. ACS Applied Materials & Interfaces. 2023, 15, 45713-45724

10. Haiyue Peng, Bo Jiang, Feize Li*, Junyuan Gong, Yingdan Zhang, Meng Yang, Ning Liu and Lijian Ma*. Single-crystal-structure directed predesign of cationic covalent organic polymers for rapidly capturing ⁹⁹TcO₄^–, Chemistry of Materials 2023, 35: 2531-2540

11. Xijian Chen, Feize Li^*, Ranxi Liang, Weihao Liu, Huan Ma, Tu Lan, Jiali Liao, Yuanyou Yang, Jijun Yang, Ning Liu*. A smart benzothiazole-based conjugated polymer nanoplatform with multistimuli response for enhanced synergistic chem-photothermal cancer therapy. ACS Applied Materials & Interfaces, 2023, 15: 16343.

12. Weihao Liu, Huan Ma, Ranxi Liang, Xijian Chen, Hongyan Li*, Tu Lan, Jijun Yang, Jiali Liao, Zhi Qin, Yuanyou Yang, Ning Liu, Feize Li*. Targeted alpha therapy of glioma using ²¹¹At-labeled heterodimeric peptide targeting both vegfr and integrins. Molecular Pharmaceutics. 2022, 19: 3206-3216.

13. Huan Ma, Feize Li*, Guohua Shen, Lili Pan, Weihao Liu, Ranxi Liang, Tu Lan, Yuanyou Yang, Jijun Yang, Jiali Liao, Ning Liu*. In vitro and in vivo evaluation of ²¹¹At-labeled fibroblast activation protein inhibitor for glioma treatment. Bioorganic Medical Chemistry. 2022, 55: 116600.

14. Ranxi Liang, Zhonghui Liao, Feize Li*, Huan Ma, Weihao Liu, Xijian Chen, Tu Lan, Yuanyou Yang, Jiali Liao, Jijun Yang, Ning Liu*. In Vitro Anticancer Ability of Nano Fluorescent ¹¹¹In-MIL-68/PEG-FA on Hela Cells. Chemistry-A European Journal. 2022, 28, e202104589.

15. Feize Li, Junshan Geng, Kongqiu Hu, Liwen Zeng, Jingyang Wang, Xianghe Kong, Ning Liu, Zhifang Chai, Lei Mei*, Weiqun Shi. Temperature-Triggered Structural Dynamics of Non-Coordinating Guest Moieties in a Fluorescent Actinide Polyrotaxane Framework. Chemistry-A European Journal. 2021, 27: 8730-8736

16. Huan Ma, Feize Li*, Guohua Shen, Huawei Cai, Weihao Liu, Tu Lan, Yuanyou Yang, Jijun Yang, Jiali Liao and Ning Liu*. Synthesis and Preliminary Evaluation of ¹³¹I-Labeled FAPI Tracers for Cancer Theranostics. Molecular Pharmaceutics, 2021, 18, 4179-4187

17. Feize Li, Junshan Geng, Kongqiu Hu, Jipan Yu, Ning Liu, Zhifang Chai, Lei Mei*, Weiqun Shi. Proximity Effect in Uranyl Coordination of the Cucurbit[6]uril-Bipyridinium Pseudorotaxane Ligand for Promoting Host-Guest Synergistic Chelating. Inorganic Chemistry. 2021, 60, 10522-10534.

18. Feize Li, Lei Mei*, Shuwen An, Kongqiu Hu, Zhifang Chai, Ning Liu* and Weiqun Shi*, Kinked-Helix Actinide Polyrotaxanes from Weakly Bound Pseudorotaxane Linkers with Variable Conformations. Inorganic Chemistry. 2020, 59, 4058-4067.

19. Feize Li, Lei Mei, Kongqiu Hu, Shuwen An, Si Wu, Ning Liu*, Zhifang Chai and Weiqun Shi*. Uranyl Compounds Involving a Weakly Bonded Pseudorotaxane Linker: Combined Effect of pH and Competing Ligands on Uranyl Coordination and Speciation. Inorganic Chemistry. 2019, 58, 5, 3271-3282.

20. Lei Mei, Feize Li, Jianhui Lan, Congzhi Wang, Chao Xu, Hao Deng, Qunyan Wu, Kongqiu Hu, Lin Wang, Zhifang Chai, Jing Chen, John K. Gibson and Weiqun Shi. Anion-adaptive crystalline cationic material for ⁹⁹TcO₄^- trapping. Nature Communications, 2019, 10, 1532.

发明专利：

1. 李飞泽; 高靖; 杨远友; 刘宁; 廖家莉; 杨吉军; 兰图。一种富集112Cd靶制备的制备方法, 2020.10.16, 中国ZL202010634014.4

2. 李飞泽; 刘宁; 廖家莉; 杨远友; 杨吉军; 一种用于溶液中铀分离的功能化水热碳材料的制备方法, 2019-10-08, 中国, ZL201710058238.3